STOCK TITAN

Novanta (NASDAQ: NOVT) boosts buyback capacity to $231M with new authorization

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Novanta Inc. reported that its Board of Directors has authorized the repurchase of up to an additional $200.0 million of its outstanding common shares. As of September 18, 2025, $31.0 million remained available under the Company’s 2020 share repurchase authorization, giving a total current repurchase capacity of $231.0 million.

Shares may be bought at the Company’s discretion over time, including via open market purchases, privately negotiated transactions or accelerated share purchase agreements, in accordance with federal securities laws. The program does not require Novanta to repurchase a specific amount, has no set end date, and may be suspended or discontinued, with actual activity depending on factors such as share price, market and economic conditions, cash availability and other investment opportunities.

Positive

  • None.

Negative

  • None.

Insights

Novanta adds $200M to a flexible, open-ended share repurchase program.

Novanta Inc. has authorized up to an additional $200.0 million of common share repurchases, bringing total available capacity to $231.0 million as of September 18, 2025. This indicates the Board’s willingness to return capital to shareholders through buybacks alongside other capital deployment options.

The authorization is highly discretionary. Repurchases can occur through open market purchases, privately negotiated deals, or accelerated share purchase agreements, but the Company is not obligated to repurchase any specific amount. The absence of a time limit and the ability to suspend or discontinue the program mean actual buyback levels will depend on management’s ongoing assessment of share price, market conditions, cash availability, legal requirements and competing growth opportunities.

The announcement also notes that certain SEC regulations may permit repurchases at times when insider trading laws might otherwise restrict activity, which can smooth execution. Future disclosures in periodic reports or subsequent announcements would show whether and how quickly this $231.0 million capacity is used.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
0001076930false00010769302025-09-172025-09-17

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 17, 2025

NOVANTA INC.

(Exact name of registrant as specified in is charter)

New Brunswick, Canada

001-35083

98-0110412

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

125 Middlesex Turnpike

Bedford, Massachusetts

01730

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (781) 266-5700

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common shares, no par value

 

NOVT

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


 

Item 8.01 Other Matters.

 

On September 18, 2025, the Novanta Inc. (the "Company") issued a press release announcing that its Board of Directors (the "Board") authorized the repurchase of up to an additional $200.0 million of the Company’s outstanding common shares. As of September 18, 2025, $31.0 million remained available for repurchase under the Company's 2020 Board share repurchase authorization, for a total available capacity of $231.0 million. Shares may be purchased on a discretionary basis from time to time at the Company’s discretion, subject to market conditions, share price, legal requirements and other considerations. Shares may also be repurchased through an accelerated share purchase agreement, on the open market or in privately negotiated transactions in accordance with applicable federal securities laws. Repurchases may be made under certain SEC regulations, which would permit common shares to be repurchased when we would otherwise be prohibited from doing so under insider trading laws. The share repurchase program does not obligate the Company to acquire any particular amount of common shares. No time limit is set for the completion of the share repurchase program, and the program may be suspended or discontinued at any time. The timing and amount of any transactions will be at the Company’s discretion, subject to the market price of the stock, general market and economic conditions, cash availability, applicable legal requirements, cash return expectations, and other growth investment opportunities.

 

 

Safe Harbor and Forward-Looking Information

Certain statements in this Current Report on Form 8-K are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and are based on current expectations and assumptions that are subject to risks and uncertainties. All statements contained in this Form 8-K that do not relate to matters of historical fact should be considered forward-looking statements, and are generally identified by words such as “expect,” “intend,” “anticipate,” “estimate,” “believe,” “future,” “could,” “should,” “plan,” “aim,” and other similar expressions. These forward-looking statements include, but are not limited to, statements regarding future share repurchases and other statements that are not historical facts. These forward-looking statements are neither promises nor guarantees, but involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various important factors, including, but not limited to, the following: economic and political conditions and the effects of these conditions on our customers’ businesses, capital expenditures and level of business activities; and other important risk factors found in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as updated by our subsequent filings with the Securities and Exchange Commission. Such statements are based on the Company’s beliefs and assumptions and on information currently available to the Company. The Company disclaims any obligation to publicly update or revise any such forward-looking statements as a result of developments occurring after the date of this document except as required by law.

 

 

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Novanta Inc.

Date: September 18, 2025

By:

/s/ Robert J. Buckley

Robert J. Buckley

Chief Financial Officer

 

 

 

 


FAQ

What share repurchase action did Novanta Inc. (NOVT) announce?

Novanta Inc. announced that its Board of Directors authorized the repurchase of up to an additional $200.0 million of the Company’s outstanding common shares.

What is Novanta Inc. (NOVT)'s total current share repurchase capacity?

As of September 18, 2025, Novanta Inc. had $31.0 million remaining under its 2020 share repurchase authorization, bringing total available repurchase capacity to $231.0 million.

How can Novanta Inc. (NOVT) execute its share repurchases?

Novanta Inc. may repurchase common shares on a discretionary basis through open market purchases, accelerated share purchase agreements, or privately negotiated transactions, in accordance with applicable federal securities laws.

Is Novanta Inc. (NOVT) required to buy back a specific amount of shares?

No. The share repurchase program does not obligate Novanta Inc. to acquire any particular amount of common shares, and activity will depend on factors such as share price, market conditions, and cash availability.

Does Novanta Inc. (NOVT)'s share repurchase program have an expiration date?

No time limit is set for completing the share repurchase program. It may be suspended or discontinued at any time at the Company’s discretion.

What factors will influence Novanta Inc. (NOVT)'s decision to repurchase shares?

Novanta Inc. states that the timing and amount of any repurchases will depend on the market price of the stock, general market and economic conditions, cash availability, legal requirements, cash return expectations, and other growth investment opportunities.